Co-Authors
This is a "connection" page, showing publications co-authored by Harald Renz and Martin Risch.
Connection Strength
1.777
-
Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study. J Clin Med. 2020 Dec 09; 9(12).
Score: 0.229
-
Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study. Clin Chem Lab Med. 2020 11 19; 59(2):e49-e51.
Score: 0.229
-
Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation. Biomed Res Int. 2020; 2020:9878453.
Score: 0.228
-
Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study. Clin Chem Lab Med. 2020 08 31; 58(12):2131-2140.
Score: 0.225
-
EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA). Diagnostics (Basel). 2020 Aug 14; 10(8).
Score: 0.224
-
Shrunken pore syndrome, preeclampsia, and markers of NO metabolism in pregnant women during the first trimester. Scand J Clin Lab Invest. 2019 Feb - Apr; 79(1-2):91-98.
Score: 0.202
-
Fibroblast growth factor 23 and renal function among young and healthy individuals. Clin Chem Lab Med. 2018 08 28; 56(9):1483-1489.
Score: 0.196
-
High first-trimester maternal blood cystatin C levels despite normal serum creatinine predict pre-eclampsia in singleton pregnancies. Scand J Clin Lab Invest. 2017 Dec; 77(8):634-643.
Score: 0.185
-
Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies. Dis Markers. 2021; 2021:8810196.
Score: 0.058